{"entity":{"id":"cancers-mdpi","kind":"journal","name":"Cancers","aka":["Cancers (Basel)"],"tldr":"A high-volume open-access oncology journal from MDPI publishing thousands of papers a year across basic, translational and clinical cancer research.","summary":"Fully open access with article processing charges and rapid turnaround, publishing thousands of original articles and reviews a year, often in special issues. Widely indexed and read, though MDPI's volume and speed have drawn scrutiny; treat individual findings with the usual care and check for replication.","asOf":"2026-09-09","links":[{"label":"MDPI","url":"https://www.mdpi.com"}],"tags":[],"related":["current-oncology-mdpi","pubmed-europepmc"],"cancers":[],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"publisher":"MDPI","url":"https://www.mdpi.com/journal/cancers","issn":"2072-6694","scope":"clinical oncology","access":"open-access","founded":2009,"matchNames":["Cancers","Cancers (Basel)"]},"route":"/journals/cancers-mdpi/","neighbours":{"journal":[{"id":"current-oncology-mdpi","kind":"journal","name":"Current oncology","route":"/journals/current-oncology-mdpi/"}],"collection":[{"id":"pubmed-europepmc","kind":"collection","name":"PubMed & Europe PMC","route":"/collections/pubmed-europepmc/"}],"paper":[{"id":"paper-cd47-colorectal-cancers-basel-2025","kind":"paper","name":"Expression and Clinical Significance of CD47 in Colorectal Cancer: A Review","route":"/key-papers/paper-cd47-colorectal-cancers-basel-2025/"},{"id":"paper-fgfr2-cholangiocarcinoma-cancers-basel-2026","kind":"paper","name":"FGFR2-Rearranged Biliary Tract Cancer: Biology, Resistance Mechanisms, and Emerging Therapeutic Strategies","route":"/key-papers/paper-fgfr2-cholangiocarcinoma-cancers-basel-2026/"},{"id":"paper-nhs-galleri-design-cancers-2022","kind":"paper","name":"NHS-Galleri: design of the largest randomised trial of a multi-cancer blood test","route":"/key-papers/paper-nhs-galleri-design-cancers-2022/"},{"id":"paper-albrecht-pdl1-western-gallbladder-cancers-2021","kind":"paper","name":"Programmed death ligand-1 (PD-L1) is an independent negative prognosticator in Western-world gallbladder cancer","route":"/key-papers/paper-albrecht-pdl1-western-gallbladder-cancers-2021/"},{"id":"paper-tebentafusp-melanoma-cancers-basel-2019","kind":"paper","name":"Tebentafusp: T Cell Redirection for the Treatment of Metastatic Uveal Melanoma","route":"/key-papers/paper-tebentafusp-melanoma-cancers-basel-2019/"}],"person":[{"id":"ruben-mesa","kind":"person","name":"Ruben Mesa","route":"/people/ruben-mesa/"},{"id":"shivaani-kummar","kind":"person","name":"Shivaani Kummar","route":"/people/shivaani-kummar/"},{"id":"tatsuya-ohno","kind":"person","name":"Tatsuya Ohno","route":"/people/tatsuya-ohno/"}]}}